About Anika Therapeutics
Anika Therapeutics (NASDAQ:ANIK) focuses on developing, manufacturing, and commercializing advanced solutions for joint health, pain management, and tissue regeneration. This company's mission is to improve the lives of patients worldwide by offering innovative therapies that advance the standard of care. Anika Therapeutics' portfolio includes hyaluronic acid products for osteoarthritis pain treatment, surgical aids in the orthopedic and other healthcare markets, and therapeutic products for tissue repair and regeneration. The company is committed to scientific excellence and operates with a vision to become a leader in delivering solutions that address unmet medical needs in its targeted markets. Through its dedication to innovation, Anika Therapeutics aims to achieve sustained growth and enhance shareholder value by expanding its product offerings and reaching more patients globally.
Snapshot
Operations
Products and/or services of Anika Therapeutics
- Orthovisc and Monovisc - hyaluronic acid-based therapies for pain relief in osteoarthritis patients.
- Cingal - combines hyaluronic acid with a steroid to provide longer-lasting pain relief from osteoarthritis.
- Hyalofast - a biodegradable support for hyaluronic acid, aiding in cartilage regeneration.
- Tactoset - an injectable, bone substitute for repairing bone defects.
- Hyalobarrier - a gel used to prevent post-surgical adhesions.
- Rotium Bioresorbable Wick - designed to enhance the repair of rotator cuff injuries by improving tendon healing.
Anika Therapeutics executive team
- Dr. Cheryl Renee Blanchard Ph.D.President, CEO & Director
- Mr. Stephen D. GriffinExecutive VP, CFO & COO
- Mr. David Colleran J.D.Executive VP, General Counsel & Corporate Secretary
- Mr. Ian W. McLeodVP & Chief Accounting Officer
- Mr. Matthew HallDirector of Corporate Development & Investor Relations
- Mr. Mark NamaroffVice President of Investor Relations, ESG & Corporate Communications
- Mr. James ChaseSenior Vice President of International Sales & Marketing
- Mr. Ben JosephVice President of Commercial & Corporate Development
- Ms. Lisa FunicielloVice President of Human Resources
- Ms. Mira LeiwantSenior Vice President of Regulatory, Quality & Clinical Affairs